Fischer Imaging and R2 Technology to Develop Breast Cancer Technology
DENVER, Sept. 19 -- Fischer Imaging Corp. and R2 Technology Inc. announced they have signed a development and marketing agreement to customize CAD technology for use with Fischer's SenoScan Full Field Digital Mammography system.
R2's CAD technology is designed to assist radiologists in detection of breast cancer.
Under the agreement, Fischer Imaging will have sole worldwide distribution rights to its SenoScan Full Field Digital Mammography System integrated with R2's CAD technology. The combination of the two devices will require FDA approval for clinical use in the US, and the companies are each preparing the FDA premarket approval supplements to obtain clearance.
The R2 ImageChecker system was originally approved by the FDA in 1998 for use with film-based screening mammography to assist radiologists in minimizing false negative readings.
For more information, visit: www.fischerimaging.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024